Search by Drug Name or NDC

    NDC 70010-0187-10 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5; 50 mg/1; mg/1 Details

    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5; 50 mg/1; mg/1

    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Granules Pharmaceuticals Inc.. The primary component is HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM.

    Product Information

    NDC 70010-0187
    Product ID 70010-187_06ce684e-c85b-e50e-e063-6294a90a440c
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 12.5; 50
    Active Ingredient Units mg/1; mg/1
    Substance Name HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
    Labeler Name Granules Pharmaceuticals Inc.
    Pharmaceutical Class Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA218015
    Listing Certified Through 2024-12-31

    Package

    NDC 70010-0187-10 (70010018710)

    NDC Package Code 70010-187-10
    Billing NDC 70010018710
    Package 1000 TABLET, FILM COATED in 1 BOTTLE (70010-187-10)
    Marketing Start Date 2023-09-29
    NDC Exclude Flag N
    Pricing Information N/A